Taylor & Francis Group
Browse

Secretory autophagy during lysosome inhibition (SALI)

Download (781.26 kB)
journal contribution
posted on 2022-07-04, 11:00 authored by Jayanta Debnath, Andrew M. Leidal

Both macroautophagy/autophagy and extracellular vesicle (EV) secretion pathways converge upon the endolysosome system. Although lysosome impairment leads to defects in autophagic degradation, the impact of such dysfunction on EV secretion remains poorly understood. Recently, we uncovered a novel secretory autophagy pathway that employs EVs and nanoparticles (EVPs) for the secretion of autophagy cargo receptors outside the cell when either autophagosome maturation or lysosomal function is blocked. We term this process secretory autophagy during lysosome inhibition (SALI). SALI functionally requires multiple steps in classical autophagosome formation and the small GTPase RAB27A. Because the intracellular accumulation of autophagy cargo receptors perturbs cell signaling and quality control pathways, we propose that SALI functions as a failsafe mechanism to preserve protein and cellular homeostasis when autophagic or lysosomal degradation is impaired.

Funding

Grant support to JD includes the NIH (CA201849, CA126792, CA213775, AG057462), Samuel Waxman Cancer Research Foundation, The Mark Foundation for Cancer Research (Endeavor Award), and UCSF QB3 Calico Longevity Fellowship (to JD and AML). Fellowship support to AML includes a Banting Postdoctoral Fellowship from the Government of Canada (201409BPF-335868) and Cancer Research Society Scholarship for Next Generation of Scientists (22805).

History